Exploring Biological Markers of Driver Fatigue for Enhanced Road Safety

NCT ID: NCT07089342

Last Updated: 2025-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-31

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess the effectiveness of biological markers in detecting fatigue/sleepiness in a sample of the general driving population in Belgium. The link between the collected biomarkers (oral fluid sample), observed signs of sleepiness in the driver and self-reported driver variables will be analysed. The analysis of the biological samples aims to measure endogenous metabolite levels that are possibly indicative for sleepiness of the donor driver. The respective metabolites will be chosen based on the results of a preceding clinical study (https://clinicaltrials.gov/study/NCT05585515). The objective of this study is to verify and validate the proposed metabolites as biomarkers for driver sleepiness in road traffic.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Researchers from NICC (National Institute of Criminalistics and Criminology) and VIAS will collect (1) saliva samples (Salivette with neutral swab allowing use by not-medically trained personnel; this sampling method is also used by the Belgian police in scope of the drugs in traffic legislation since 2019), (2) self-reported driver data (survey) and (3) observed driver data (form filled in by researchers) from drivers that were stopped on the road in scope of routine police checks. The collaboration with the police is because police can stop drivers randomly on-road while researchers cannot. After the police check, a researcher will ask if the driver wants to participate in a study on driver fatigue which is entirely independent from the police check. Voluntary drivers sign an informed consent form.

The collected saliva samples will be entirely separate from any sample obtained during the police checks. During data collection, the saliva sample, driver survey and observation form will each get a unique identification code to link the data. Afterwards, the researchers will work with this anonymised number and the data cannot be traced back to the participant.

All anonymised samples/data will temporarily be stored at NICC (Dept. Toxicology) and then be sent to the University of Zurich for analysis. The analysis of the saliva samples aims to measure endogenous metabolite levels that are possibly indicative for sleepiness of the donor. The correlation of the biomarker levels with observed/reported driver data will be measured. In specific cases the co-existence of drugs/medication in the saliva samples may also be tested: when the donor reported the consumption of the respective substance in the driver survey, as a confirmatory analysis, and (2) when the researchers believe the co-consumption of drugs/medication may interfere with the primary analysis. All anonymised samples will be stored at the University of Zurich for a maximum of 10 years and then be destroyed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drowsiness Sleepiness Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Road traffic population

People randomly stopped by police in public road traffic

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* drivers randomly stopped by the police

Exclusion Criteria

* refusal to sign informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vias Institute Brussel

UNKNOWN

Sponsor Role collaborator

Nationaal Instituut voor Criminalistiek en Criminologie Brussel

UNKNOWN

Sponsor Role collaborator

University of Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vias institute

Brussels, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sofie Boets

Role: CONTACT

+32 2 244 14 12

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EC-2025-141

Identifier Type: OTHER

Identifier Source: secondary_id

EC-2025-141

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Chronic Sleep Restriction
NCT01493661 COMPLETED
Pain in Long COVID-19: the Role of Sleep
NCT05606211 ACTIVE_NOT_RECRUITING
Exploring the Link Between Sleep and Brain Clearance
NCT05539378 ENROLLING_BY_INVITATION NA